Quick Heal Technologies Intrinsic Value
Quick Heal Technologies intrinsic value. Quick Heal Technologies (QUICKHEAL) median intrinsic value is ₹55.16 from 3 valuation models (range ₹41–₹81), vs current price ₹137.91 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read QUICKHEAL dividend growth for the complete payout history and dividend yield track record.
QUICKHEAL Valuation Methods Summary — DCF, Graham Number & P/E
Quick Heal Technologies intrinsic value across 3 models vs current price ₹137.91 — upside/downside and value range per method. For current market price and key ratios, visit Quick Heal Technologies share price today.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹80.93 | ₹72.84 - ₹89.02 | -41.3% | Book Value/Share: ₹80.93, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹41.37 | ₹37.23 - ₹45.51 | -70.0% | Revenue/Share: ₹39.26, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹55.16 | ₹44.13 - ₹66.19 | -60.0% | CF Growth: 5.0%, Discount: 15% |
QUICKHEAL Intrinsic Value vs Market Price — All Valuation Models
Quick Heal Technologies fair value range ₹41–₹81 vs current market price ₹137.91 across 3 valuation models. Compare with Quick Heal Technologies value estimation to assess whether the stock is under or overvalued.
QUICKHEAL Intrinsic Value Analysis — Undervalued or Overvalued?
Quick Heal Technologies median intrinsic value ₹55.16, current price ₹137.91 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of QUICKHEAL?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Quick Heal Technologies (QUICKHEAL) is ₹55.16 (median value). With the current market price of ₹137.91, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹41.37 to ₹80.93, indicating ₹41.37 - ₹80.93.
Is QUICKHEAL undervalued or overvalued?
Based on our multi-method analysis, Quick Heal Technologies (QUICKHEAL) appears to be trading above calculated value by approximately 60.0%.
QUICKHEAL Financial Health — Key Ratios vs Industry Benchmarks
Quick Heal Technologies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 184.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -18.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -60.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.39x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
QUICKHEAL Cash Flow Quality — Operating & Free Cash Flow
Quick Heal Technologies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹15 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹-22 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹18 Cr | ₹18 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹31 Cr | ₹31 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹80 Cr | ₹80 Cr | Positive Free Cash Flow | 8/10 |